Critical appraisal:Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM 2010 2
From Cancer Guidelines Wiki
Risk of bias assessment: cohort study
"New technology" group
- Representative of eligible patients.
- Representative of eligible patients
Comparability of groups on demographic characteristics and clinical features
Measurement of outcomes
Same method of measurement used across comparison groups
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
- Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
|Low risk of bias||Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating|
- Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008. Pediatr Dermatol 2010 May;27(3):244-54 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20403119.
- Assigned to
- Topic area
- Clinical question
Section below only relevant for Cancer Council Project Officer